APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intestinal Anti-infective Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Intestinal Anti-infective Drugs Industry Growth and Trends Forecast to 2032

27 December 2025122 pages

Choose your research edition.

Industry ResearchIntestinal Anti-infective Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Intestinal Anti-infective Drugs Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Intestinal Anti-infective Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intestinal Anti-infective Drugs Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Intestinal Anti-infective Drugs Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Intestinal Anti-infective Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Intestinal Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Intestinal Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intestinal Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intestinal Anti-infective Drugs include Chongqing Sino Biopharmaceutical Co., Ltd., Chongqing Laimi Pharmaceutical Co., Ltd., Zhejiang Deer Pharmaceutical Co., Ltd., Yunnan Weihe Pharmaceutical Co., Ltd., Yangzhou Sanyao Pharmaceutical Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd., Teyi Pharmaceutical Group Co., Ltd., Sichuan Ziligong Pharmaceutical Co., Ltd. and Shaanxi Kaiyuan Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Intestinal Anti-infective Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intestinal Anti-infective Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intestinal Anti-infective Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intestinal Anti-infective Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intestinal Anti-infective Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intestinal Anti-infective Drugs Market by Company

Chongqing Sino Biopharmaceutical Co., Ltd.

Chongqing Laimi Pharmaceutical Co., Ltd.

Zhejiang Deer Pharmaceutical Co., Ltd.

Yunnan Weihe Pharmaceutical Co., Ltd.

Yangzhou Sanyao Pharmaceutical Co., Ltd.

Tiansheng Pharmaceutical Group Co., Ltd.

Teyi Pharmaceutical Group Co., Ltd.

Sichuan Ziligong Pharmaceutical Co., Ltd.

Shaanxi Kaiyuan Pharmaceutical Co., Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd.

Nanjing Chengong Pharmaceutical Co., Ltd.

Lingyuan Pharmaceutical Co., Ltd.

Jiangxi Pharmaceutical Co., Ltd.

Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.

Jilin Jibang Pharmaceutical Co., Ltd.

Jilin Fukang Pharmaceutical Co., Ltd.

Hubei Hendi Pharmaceutical Co., Ltd.

Hainan Hailing Chemical Pharmaceutical Co., Ltd.

Fujian Sanming Tiantai Pharmaceutical Co., Ltd.

Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.

Vox Nutrition

Teva Pharmaceuticals

Salix Pharmaceuticals

Otto Chemie Pvt Ltd

Medikonda Nutrients

Botanic Healthcare

AdvaCare Pharma

Intestinal Anti-infective Drugs Segment by Type

Neomycin

Berberine

Rifaximin

Intestinal Anti-infective Drugs Segment by Application

Pharmacy

Hospital

Clinic

Other

Intestinal Anti-infective Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intestinal Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intestinal Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intestinal Anti-infective Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intestinal Anti-infective Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intestinal Anti-infective Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Neomycin Table 2. Major Company of Berberine Table 3. Major Company of Rifaximin Table 4. Global Intestinal Anti-infective Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Intestinal Anti-infective Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Intestinal Anti-infective Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Intestinal Anti-infective Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Intestinal Anti-infective Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Intestinal Anti-infective Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Intestinal Anti-infective Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Intestinal Anti-infective Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Intestinal Anti-infective Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Intestinal Anti-infective Drugs Industry Trends Table 26. Intestinal Anti-infective Drugs Industry Drivers Table 27. Intestinal Anti-infective Drugs Industry Opportunities and Challenges Table 28. Intestinal Anti-infective Drugs Industry Restraints Table 29. Global Intestinal Anti-infective Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Intestinal Anti-infective Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Intestinal Anti-infective Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Intestinal Anti-infective Drugs Sales Share by Company (2021-2026) Table 33. Global Intestinal Anti-infective Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Intestinal Anti-infective Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Intestinal Anti-infective Drugs Major Company Production Sites and Headquarters Table 36. Global Intestinal Anti-infective Drugs Company, Product Type & Application Table 37. Global Intestinal Anti-infective Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Intestinal Anti-infective Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Intestinal Anti-infective Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Intestinal Anti-infective Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Intestinal Anti-infective Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Intestinal Anti-infective Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Intestinal Anti-infective Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Intestinal Anti-infective Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Intestinal Anti-infective Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Intestinal Anti-infective Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Intestinal Anti-infective Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Intestinal Anti-infective Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Intestinal Anti-infective Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Intestinal Anti-infective Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Intestinal Anti-infective Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Intestinal Anti-infective Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Intestinal Anti-infective Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Intestinal Anti-infective Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Intestinal Anti-infective Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Intestinal Anti-infective Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Intestinal Anti-infective Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Chongqing Sino Biopharmaceutical Co., Ltd. Company Information Table 73. Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview Table 74. Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 76. Chongqing Sino Biopharmaceutical Co., Ltd. Recent Development Table 77. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information Table 78. Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview Table 79. Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 81. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Development Table 82. Zhejiang Deer Pharmaceutical Co., Ltd. Company Information Table 83. Zhejiang Deer Pharmaceutical Co., Ltd. Business Overview Table 84. Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 86. Zhejiang Deer Pharmaceutical Co., Ltd. Recent Development Table 87. Yunnan Weihe Pharmaceutical Co., Ltd. Company Information Table 88. Yunnan Weihe Pharmaceutical Co., Ltd. Business Overview Table 89. Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 91. Yunnan Weihe Pharmaceutical Co., Ltd. Recent Development Table 92. Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information Table 93. Yangzhou Sanyao Pharmaceutical Co., Ltd. Business Overview Table 94. Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 96. Yangzhou Sanyao Pharmaceutical Co., Ltd. Recent Development Table 97. Tiansheng Pharmaceutical Group Co., Ltd. Company Information Table 98. Tiansheng Pharmaceutical Group Co., Ltd. Business Overview Table 99. Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 101. Tiansheng Pharmaceutical Group Co., Ltd. Recent Development Table 102. Teyi Pharmaceutical Group Co., Ltd. Company Information Table 103. Teyi Pharmaceutical Group Co., Ltd. Business Overview Table 104. Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 106. Teyi Pharmaceutical Group Co., Ltd. Recent Development Table 107. Sichuan Ziligong Pharmaceutical Co., Ltd. Company Information Table 108. Sichuan Ziligong Pharmaceutical Co., Ltd. Business Overview Table 109. Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 111. Sichuan Ziligong Pharmaceutical Co., Ltd. Recent Development Table 112. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information Table 113. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview Table 114. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 116. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Development Table 117. Shandong Xinhua Pharmaceutical Co., Ltd. Company Information Table 118. Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview Table 119. Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 121. Shandong Xinhua Pharmaceutical Co., Ltd. Recent Development Table 122. Nanjing Chengong Pharmaceutical Co., Ltd. Company Information Table 123. Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview Table 124. Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 126. Nanjing Chengong Pharmaceutical Co., Ltd. Recent Development Table 127. Lingyuan Pharmaceutical Co., Ltd. Company Information Table 128. Lingyuan Pharmaceutical Co., Ltd. Business Overview Table 129. Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 131. Lingyuan Pharmaceutical Co., Ltd. Recent Development Table 132. Jiangxi Pharmaceutical Co., Ltd. Company Information Table 133. Jiangxi Pharmaceutical Co., Ltd. Business Overview Table 134. Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 136. Jiangxi Pharmaceutical Co., Ltd. Recent Development Table 137. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information Table 138. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Business Overview Table 139. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 141. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Recent Development Table 142. Jilin Jibang Pharmaceutical Co., Ltd. Company Information Table 143. Jilin Jibang Pharmaceutical Co., Ltd. Business Overview Table 144. Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 146. Jilin Jibang Pharmaceutical Co., Ltd. Recent Development Table 147. Jilin Fukang Pharmaceutical Co., Ltd. Company Information Table 148. Jilin Fukang Pharmaceutical Co., Ltd. Business Overview Table 149. Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 151. Jilin Fukang Pharmaceutical Co., Ltd. Recent Development Table 152. Hubei Hendi Pharmaceutical Co., Ltd. Company Information Table 153. Hubei Hendi Pharmaceutical Co., Ltd. Business Overview Table 154. Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 156. Hubei Hendi Pharmaceutical Co., Ltd. Recent Development Table 157. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information Table 158. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview Table 159. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 161. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Development Table 162. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Company Information Table 163. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Business Overview Table 164. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 166. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Recent Development Table 167. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information Table 168. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Business Overview Table 169. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 171. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Recent Development Table 172. Vox Nutrition Company Information Table 173. Vox Nutrition Business Overview Table 174. Vox Nutrition Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Vox Nutrition Intestinal Anti-infective Drugs Product Portfolio Table 176. Vox Nutrition Recent Development Table 177. Teva Pharmaceuticals Company Information Table 178. Teva Pharmaceuticals Business Overview Table 179. Teva Pharmaceuticals Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Teva Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio Table 181. Teva Pharmaceuticals Recent Development Table 182. Salix Pharmaceuticals Company Information Table 183. Salix Pharmaceuticals Business Overview Table 184. Salix Pharmaceuticals Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Salix Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio Table 186. Salix Pharmaceuticals Recent Development Table 187. Otto Chemie Pvt Ltd Company Information Table 188. Otto Chemie Pvt Ltd Business Overview Table 189. Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Product Portfolio Table 191. Otto Chemie Pvt Ltd Recent Development Table 192. Medikonda Nutrients Company Information Table 193. Medikonda Nutrients Business Overview Table 194. Medikonda Nutrients Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 195. Medikonda Nutrients Intestinal Anti-infective Drugs Product Portfolio Table 196. Medikonda Nutrients Recent Development Table 197. Botanic Healthcare Company Information Table 198. Botanic Healthcare Business Overview Table 199. Botanic Healthcare Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 200. Botanic Healthcare Intestinal Anti-infective Drugs Product Portfolio Table 201. Botanic Healthcare Recent Development Table 202. AdvaCare Pharma Company Information Table 203. AdvaCare Pharma Business Overview Table 204. AdvaCare Pharma Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 205. AdvaCare Pharma Intestinal Anti-infective Drugs Product Portfolio Table 206. AdvaCare Pharma Recent Development Table 207. North America Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 208. North America Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 209. North America Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2026) Table 210. North America Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 211. North America Intestinal Anti-infective Drugs Sales Market Share Forecast by Country (2027-2032) Table 212. North America Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 213. North America Intestinal Anti-infective Drugs Market Size by Country (2021-2026) & (US$ Million) Table 214. North America Intestinal Anti-infective Drugs Market Share by Country (2021-2026) Table 215. North America Intestinal Anti-infective Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 216. North America Intestinal Anti-infective Drugs Market Share Forecast by Country (2027-2032) Table 217. Europe Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 218. Europe Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 219. Europe Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2026) Table 220. Europe Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 221. Europe Intestinal Anti-infective Drugs Sales Market Share Forecast by Country (2027-2032) Table 222. Europe Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 223. Europe Intestinal Anti-infective Drugs Market Size by Country (2021-2026) & (US$ Million) Table 224. Europe Intestinal Anti-infective Drugs Market Share by Country (2021-2026) Table 225. Europe Intestinal Anti-infective Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 226. Europe Intestinal Anti-infective Drugs Market Share Forecast by Country (2027-2032) Table 227. Asia-Pacific Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 228. Asia-Pacific Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 229. Asia-Pacific Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2026) Table 230. Asia-Pacific Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 231. Asia-Pacific Intestinal Anti-infective Drugs Sales Market Share Forecast by Country (2027-2032) Table 232. Asia-Pacific Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 233. Asia-Pacific Intestinal Anti-infective Drugs Market Size by Country (2021-2026) & (US$ Million) Table 234. Asia-Pacific Intestinal Anti-infective Drugs Market Share by Country (2021-2026) Table 235. Asia-Pacific Intestinal Anti-infective Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 236. Asia-Pacific Intestinal Anti-infective Drugs Market Share Forecast by Country (2027-2032) Table 237. Latin America Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 238. Latin America Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 239. Latin America Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2026) Table 240. Latin America Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 241. Latin America Intestinal Anti-infective Drugs Sales Market Share Forecast by Country (2027-2032) Table 242. Latin America Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 243. Latin America Intestinal Anti-infective Drugs Market Size by Country (2021-2026) & (US$ Million) Table 244. Latin America Intestinal Anti-infective Drugs Market Share by Country (2021-2026) Table 245. Latin America Intestinal Anti-infective Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 246. Latin America Intestinal Anti-infective Drugs Market Share Forecast by Country (2027-2032) Table 247. Middle East and Africa Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 248. Middle East and Africa Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 249. Middle East and Africa Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2026) Table 250. Middle East and Africa Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 251. Middle East and Africa Intestinal Anti-infective Drugs Sales Market Share Forecast by Country (2027-2032) Table 252. Middle East and Africa Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 253. Middle East and Africa Intestinal Anti-infective Drugs Market Size by Country (2021-2026) & (US$ Million) Table 254. Middle East and Africa Intestinal Anti-infective Drugs Market Share by Country (2021-2026) Table 255. Middle East and Africa Intestinal Anti-infective Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 256. Middle East and Africa Intestinal Anti-infective Drugs Market Share Forecast by Country (2027-2032) Table 257. Key Raw Materials Table 258. Raw Materials Key Suppliers Table 259. Intestinal Anti-infective Drugs Distributors List Table 260. Intestinal Anti-infective Drugs Customers List Table 261. Research Programs/Design for This Report Table 262. Authors List of This Report Table 263. Secondary Sources Table 264. Primary Sources List of Figures Figure 1. Intestinal Anti-infective Drugs Image Figure 2. Global Intestinal Anti-infective Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intestinal Anti-infective Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Intestinal Anti-infective Drugs Sales (2021-2032) & (K Units) Figure 5. Neomycin Image Figure 6. Global Neomycin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Berberine Image Figure 8. Global Berberine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Rifaximin Image Figure 10. Global Rifaximin Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Intestinal Anti-infective Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Intestinal Anti-infective Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Intestinal Anti-infective Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Intestinal Anti-infective Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Intestinal Anti-infective Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Intestinal Anti-infective Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Intestinal Anti-infective Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Intestinal Anti-infective Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Intestinal Anti-infective Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Intestinal Anti-infective Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Intestinal Anti-infective Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Intestinal Anti-infective Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Intestinal Anti-infective Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Intestinal Anti-infective Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Intestinal Anti-infective Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Intestinal Anti-infective Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Intestinal Anti-infective Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Intestinal Anti-infective Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Intestinal Anti-infective Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Intestinal Anti-infective Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Intestinal Anti-infective Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Intestinal Anti-infective Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Intestinal Anti-infective Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Intestinal Anti-infective Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Intestinal Anti-infective Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Intestinal Anti-infective Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Intestinal Anti-infective Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Intestinal Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Intestinal Anti-infective Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Intestinal Anti-infective Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Intestinal Anti-infective Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Intestinal Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Intestinal Anti-infective Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Intestinal Anti-infective Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Intestinal Anti-infective Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Intestinal Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Intestinal Anti-infective Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Intestinal Anti-infective Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Intestinal Anti-infective Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Intestinal Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Intestinal Anti-infective Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Intestinal Anti-infective Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Intestinal Anti-infective Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Intestinal Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Intestinal Anti-infective Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Intestinal Anti-infective Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Intestinal Anti-infective Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Pro

Scope & coverage.

Types
  • Neomycin
  • Berberine
  • Rifaximin
Applications
  • Pharmacy
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Sino Biopharmaceutical Co., Ltd.
  • Chongqing Laimi Pharmaceutical Co., Ltd.
  • Zhejiang Deer Pharmaceutical Co., Ltd.
  • Yunnan Weihe Pharmaceutical Co., Ltd.
  • Yangzhou Sanyao Pharmaceutical Co., Ltd.
  • Tiansheng Pharmaceutical Group Co., Ltd.
  • Teyi Pharmaceutical Group Co., Ltd.
  • Sichuan Ziligong Pharmaceutical Co., Ltd.
  • Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Nanjing Chengong Pharmaceutical Co., Ltd.
  • Lingyuan Pharmaceutical Co., Ltd.
  • Jiangxi Pharmaceutical Co., Ltd.
  • Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
  • Jilin Jibang Pharmaceutical Co., Ltd.
  • Jilin Fukang Pharmaceutical Co., Ltd.
  • Hubei Hendi Pharmaceutical Co., Ltd.
  • Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  • Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
  • Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
  • Vox Nutrition
  • Teva Pharmaceuticals
  • Salix Pharmaceuticals
  • Otto Chemie Pvt Ltd
  • Medikonda Nutrients
  • Botanic Healthcare
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intestinal Anti-infective Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intestinal Anti-infective Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intestinal Anti-infective Drugs Market by Type
  6. 1.3.1 Neomycin
  7. 1.3.2 Berberine
  8. 1.3.3 Rifaximin
  9. 1.4 Global Intestinal Anti-infective Drugs Market Size by Type
  10. 1.4.1 Global Intestinal Anti-infective Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Intestinal Anti-infective Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Intestinal Anti-infective Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Intestinal Anti-infective Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Intestinal Anti-infective Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Intestinal Anti-infective Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Intestinal Anti-infective Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Intestinal Anti-infective Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intestinal Anti-infective Drugs Industry Trends
  2. 2.2 Intestinal Anti-infective Drugs Industry Drivers
  3. 2.3 Intestinal Anti-infective Drugs Industry Opportunities and Challenges
  4. 2.4 Intestinal Anti-infective Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intestinal Anti-infective Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Intestinal Anti-infective Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Intestinal Anti-infective Drugs Price (2021-2026)
  4. 3.4 Global Intestinal Anti-infective Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intestinal Anti-infective Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Intestinal Anti-infective Drugs Company, Product Type & Application
  7. 3.7 Global Intestinal Anti-infective Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intestinal Anti-infective Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intestinal Anti-infective Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intestinal Anti-infective Drugs Tier 1, Tier 2, and Tier 3
4 Intestinal Anti-infective Drugs Regional Status and Outlook
  1. 4.1 Global Intestinal Anti-infective Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intestinal Anti-infective Drugs Historic Market Size by Region
  3. 4.2.1 Global Intestinal Anti-infective Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intestinal Anti-infective Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intestinal Anti-infective Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intestinal Anti-infective Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Intestinal Anti-infective Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intestinal Anti-infective Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intestinal Anti-infective Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intestinal Anti-infective Drugs by Application
  1. 5.1 Intestinal Anti-infective Drugs Market by Application
  2. 5.1.1 Pharmacy
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.1.4 Other
  6. 5.2 Global Intestinal Anti-infective Drugs Market Size by Application
  7. 5.2.1 Global Intestinal Anti-infective Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Intestinal Anti-infective Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Intestinal Anti-infective Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Intestinal Anti-infective Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Intestinal Anti-infective Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Intestinal Anti-infective Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Intestinal Anti-infective Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Intestinal Anti-infective Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Sino Biopharmaceutical Co., Ltd.
  2. 6.1.1 Chongqing Sino Biopharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  6. 6.1.5 Chongqing Sino Biopharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Chongqing Laimi Pharmaceutical Co., Ltd.
  8. 6.2.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  12. 6.2.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Zhejiang Deer Pharmaceutical Co., Ltd.
  14. 6.3.1 Zhejiang Deer Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Zhejiang Deer Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  18. 6.3.5 Zhejiang Deer Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Yunnan Weihe Pharmaceutical Co., Ltd.
  20. 6.4.1 Yunnan Weihe Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Yunnan Weihe Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  24. 6.4.5 Yunnan Weihe Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Yangzhou Sanyao Pharmaceutical Co., Ltd.
  26. 6.5.1 Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Yangzhou Sanyao Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  30. 6.5.5 Yangzhou Sanyao Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Tiansheng Pharmaceutical Group Co., Ltd.
  32. 6.6.1 Tiansheng Pharmaceutical Group Co., Ltd. Company Information
  33. 6.6.2 Tiansheng Pharmaceutical Group Co., Ltd. Business Overview
  34. 6.6.3 Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  36. 6.6.5 Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments
  37. 6.7 Teyi Pharmaceutical Group Co., Ltd.
  38. 6.7.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
  39. 6.7.2 Teyi Pharmaceutical Group Co., Ltd. Business Overview
  40. 6.7.3 Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  42. 6.7.5 Teyi Pharmaceutical Group Co., Ltd. Recent Developments
  43. 6.8 Sichuan Ziligong Pharmaceutical Co., Ltd.
  44. 6.8.1 Sichuan Ziligong Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Sichuan Ziligong Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  48. 6.8.5 Sichuan Ziligong Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  50. 6.9.1 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  54. 6.9.5 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Shandong Xinhua Pharmaceutical Co., Ltd.
  56. 6.10.1 Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  60. 6.10.5 Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Nanjing Chengong Pharmaceutical Co., Ltd.
  62. 6.11.1 Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  66. 6.11.5 Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Lingyuan Pharmaceutical Co., Ltd.
  68. 6.12.1 Lingyuan Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Lingyuan Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  72. 6.12.5 Lingyuan Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Jiangxi Pharmaceutical Co., Ltd.
  74. 6.13.1 Jiangxi Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Jiangxi Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  78. 6.13.5 Jiangxi Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
  80. 6.14.1 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  84. 6.14.5 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Jilin Jibang Pharmaceutical Co., Ltd.
  86. 6.15.1 Jilin Jibang Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Jilin Jibang Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  90. 6.15.5 Jilin Jibang Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Jilin Fukang Pharmaceutical Co., Ltd.
  92. 6.16.1 Jilin Fukang Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Jilin Fukang Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  96. 6.16.5 Jilin Fukang Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Hubei Hendi Pharmaceutical Co., Ltd.
  98. 6.17.1 Hubei Hendi Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Hubei Hendi Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  102. 6.17.5 Hubei Hendi Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  104. 6.18.1 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information
  105. 6.18.2 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview
  106. 6.18.3 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  108. 6.18.5 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Developments
  109. 6.19 Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
  110. 6.19.1 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Company Information
  111. 6.19.2 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Business Overview
  112. 6.19.3 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  114. 6.19.5 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Recent Developments
  115. 6.20 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
  116. 6.20.1 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information
  117. 6.20.2 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Business Overview
  118. 6.20.3 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  120. 6.20.5 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Recent Developments
  121. 6.21 Vox Nutrition
  122. 6.21.1 Vox Nutrition Company Information
  123. 6.21.2 Vox Nutrition Business Overview
  124. 6.21.3 Vox Nutrition Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Vox Nutrition Intestinal Anti-infective Drugs Product Portfolio
  126. 6.21.5 Vox Nutrition Recent Developments
  127. 6.22 Teva Pharmaceuticals
  128. 6.22.1 Teva Pharmaceuticals Company Information
  129. 6.22.2 Teva Pharmaceuticals Business Overview
  130. 6.22.3 Teva Pharmaceuticals Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Teva Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio
  132. 6.22.5 Teva Pharmaceuticals Recent Developments
  133. 6.23 Salix Pharmaceuticals
  134. 6.23.1 Salix Pharmaceuticals Company Information
  135. 6.23.2 Salix Pharmaceuticals Business Overview
  136. 6.23.3 Salix Pharmaceuticals Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Salix Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio
  138. 6.23.5 Salix Pharmaceuticals Recent Developments
  139. 6.24 Otto Chemie Pvt Ltd
  140. 6.24.1 Otto Chemie Pvt Ltd Company Information
  141. 6.24.2 Otto Chemie Pvt Ltd Business Overview
  142. 6.24.3 Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Product Portfolio
  144. 6.24.5 Otto Chemie Pvt Ltd Recent Developments
  145. 6.25 Medikonda Nutrients
  146. 6.25.1 Medikonda Nutrients Company Information
  147. 6.25.2 Medikonda Nutrients Business Overview
  148. 6.25.3 Medikonda Nutrients Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Medikonda Nutrients Intestinal Anti-infective Drugs Product Portfolio
  150. 6.25.5 Medikonda Nutrients Recent Developments
  151. 6.26 Botanic Healthcare
  152. 6.26.1 Botanic Healthcare Company Information
  153. 6.26.2 Botanic Healthcare Business Overview
  154. 6.26.3 Botanic Healthcare Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Botanic Healthcare Intestinal Anti-infective Drugs Product Portfolio
  156. 6.26.5 Botanic Healthcare Recent Developments
  157. 6.27 AdvaCare Pharma
  158. 6.27.1 AdvaCare Pharma Company Information
  159. 6.27.2 AdvaCare Pharma Business Overview
  160. 6.27.3 AdvaCare Pharma Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 AdvaCare Pharma Intestinal Anti-infective Drugs Product Portfolio
  162. 6.27.5 AdvaCare Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Intestinal Anti-infective Drugs Sales by Country
  2. 7.1.1 North America Intestinal Anti-infective Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intestinal Anti-infective Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intestinal Anti-infective Drugs Market Size by Country
  6. 7.2.1 North America Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intestinal Anti-infective Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Intestinal Anti-infective Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intestinal Anti-infective Drugs Sales by Country
  2. 8.1.1 Europe Intestinal Anti-infective Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intestinal Anti-infective Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intestinal Anti-infective Drugs Market Size by Country
  6. 8.2.1 Europe Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intestinal Anti-infective Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intestinal Anti-infective Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intestinal Anti-infective Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Intestinal Anti-infective Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intestinal Anti-infective Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intestinal Anti-infective Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intestinal Anti-infective Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intestinal Anti-infective Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intestinal Anti-infective Drugs Sales by Country
  2. 10.1.1 South America Intestinal Anti-infective Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intestinal Anti-infective Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intestinal Anti-infective Drugs Market Size by Country
  6. 10.2.1 South America Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intestinal Anti-infective Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Intestinal Anti-infective Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intestinal Anti-infective Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Intestinal Anti-infective Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intestinal Anti-infective Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intestinal Anti-infective Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Intestinal Anti-infective Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intestinal Anti-infective Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intestinal Anti-infective Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intestinal Anti-infective Drugs Value Chain Analysis
  2. 12.1.1 Intestinal Anti-infective Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intestinal Anti-infective Drugs Production Mode & Process
  7. 12.2 Intestinal Anti-infective Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intestinal Anti-infective Drugs Distributors
  10. 12.2.3 Intestinal Anti-infective Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst